HSP90AA1 and acute myeloid leukemia: Another CDK inhibitor, dinaciclib, synergized with the novel HSP90 inhibitor HAA2020 and displayed stronger apoptotic and cell cycle control properties in acute myeloid leukemia (AML) [100].